Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells
- DOI
- 10.3390/pharmaceutics16091112
- Published
- 2024-08-23
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics16091112,
title = {Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells},
author = {Larissa J. Lubitz and Moritz P. Haffner and Harden Rieger and Gero Leneweit},
year = {2024},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics16091112},
url = {https://doi.org/10.3390/pharmaceutics16091112}
}RIS
TY - JOUR TI - Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells AU - Larissa J. Lubitz AU - Moritz P. Haffner AU - Harden Rieger AU - Gero Leneweit PY - 2024 JO - Pharmaceutics DO - 10.3390/pharmaceutics16091112 UR - https://doi.org/10.3390/pharmaceutics16091112 ER -
APA
Lubitz, L. J., Haffner, M. P., Rieger, H., & Leneweit, G. (2024). Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16091112
Source records
- crossref · retrieved 2026-09-26T14:54:08.749Z